Back to Search
JEAN-PIERRE LINDENMAYER, M.D.
M.D.
Psychiatry Physician
NPI: 1871652958Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
118972(NY)
Clinical Trials (2)
2
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
The relationship of cognitive improvement after cognitive remediation with social functioning in patients with schizophrenia and severe cognitive deficits.
PMID 28094171·Schizophr Res·2017
8-other
A randomized controlled trial of cognitive remediation among inpatients with persistent mental illness.
PMID 18308903·Psychiatr Serv·2008
2-rct
Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response.
PMID 19497244·J Clin Psychiatry·2009
4-observational
The efficacy and tolerability of once-daily extended release quetiapine fumarate in hospitalized patients with acute schizophrenia: a 6-week randomized, double-blind, placebo-controlled study.
PMID 18779774·Psychopharmacol Bull·2008
2-rct
Dimensions of psychosis in patients with bipolar mania as measured by the positive and negative syndrome scale.
PMID 18441528·Psychopathology·2008
8-other
A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.
PMID 17388705·J Clin Psychiatry·2007
4-observational
Long-term safety and tolerability of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder.
PMID 17049818·Eur Neuropsychopharmacol·2007
4-observational
Minimal injection site pain and high patient satisfaction during treatment with long-acting risperidone.
PMID 15933482·Int Clin Psychopharmacol·2005
3-trial
Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
PMID 15323593·J Clin Psychiatry·2004
3-trial
An excitement subscale of the Positive and Negative Syndrome Scale.
PMID 15099614·Schizophr Res·2004
1-meta
The InterSePT scale for suicidal thinking reliability and validity.
PMID 12892870·Schizophr Res·2003
3-trial
Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
PMID 12562575·Am J Psychiatry·2003
3-trial
Hyperglycemia associated with the use of atypical antipsychotics.
PMID 11603883·J Clin Psychiatry·2001
6-review
Olanzapine for schizophrenia refractory to typical and atypical antipsychotics: an open-label, prospective trial.
PMID 11476131·J Clin Psychopharmacol·2001
8-other
Use of sodium valproate in violent and aggressive behaviors: a critical review.
PMID 10732659·J Clin Psychiatry·2000
6-review
Pharmacological treatment strategies for schizophrenia.
PMID 15853589·Expert Rev Neurother·2004
4-observational
Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.
PMID 12416603·J Clin Psychiatry·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 18 EAST 77TH STREET
NEW YORK, NY 10021 - Phone
- (212) 249-2720
Quick Facts
- NPI
- 1871652958
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile